Brief: Theradiag says study including infliximab published in Journal of Crohn's and Colitis
29/04/2015 17:55
April 29 (Reuters) - Theradiag SA ALTHE.PA :
* Says study including infliximab has been published in
Journal of Crohn's and Colitis
* Study shows that monitoring of trough levels of
infliximab, stable antibodies to infliximab and C-Reactive
Protein (CRP) can predict loss of response in Inflammatory Bowel
Disease (IBD) patients
Source text for Eikon: ID:nBw7NyVJ7a
Further company coverage: ALTHE.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 6983920;))